Which has grown faster, ALLO or CRMD?

Over the past five years, CRMD grew revenue faster — ALLO at a -34.47% CAGR versus CRMD at 352.03%.

Is ALLO or CRMD more profitable?

CRMD runs the higher net margin — ALLO at -3566.68% versus CRMD at 40.49%.

How have ALLO and CRMD total returns compared?

Over the past 5 years, ALLO delivered -42.72% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.

Allogene Therapeutics, Inc. (ALLO) vs CorMedix Inc. (CRMD)

A side-by-side comparison of Allogene Therapeutics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALLO

Allogene Therapeutics, Inc.

$507M

$1.47HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

CRMD

CorMedix Inc.

$564M

$7.19HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

Total return — ALLO vs CRMD

growth of $100 · dividends reinvested · last 8y

ALLO -94.0% (-29.6%/yr)CRMD +11.7% (+1.4%/yr)CRMD compounded faster over this window

Log scale — wide-divergence pair

ALLO CRMD

ALLO vs CRMD: by the numbers

•CRMD is the larger company ($564M vs $507M market cap).
•CRMD is profitable (40.49% net margin) while ALLO runs a net loss (-3566.68%).
•CRMD grew revenue faster over the past five years (352.03% vs -34.47% CAGR).

Metrics side by side

Valuation

Metric	ALLO	CRMD
P/E ratio	N/A	3.37
Forward P/E	N/A	14.52
P/S ratio	109.35	1.22
P/B ratio	1.16	1.22
EV / EBITDA	N/A	1.79
FCF yield	N/A	44.38%

Profitability

Metric	ALLO	CRMD
Gross margin	0.00%	82.78%
Operating margin	0.00%	46.95%
Net margin	-3566.68%	40.49%
ROE	-37.94%	40.62%
ROIC	-34.79%	27.87%

Growth (annualized)

Metric	ALLO	CRMD
Revenue CAGR (5Y)	-34.47%	352.03%
Total return CAGR (5Y)	-42.72%	9.70%

Frequently asked

Which has grown faster, ALLO or CRMD?: Over the past five years, CRMD grew revenue faster — ALLO at a -34.47% CAGR versus CRMD at 352.03%.
Is ALLO or CRMD more profitable?: CRMD runs the higher net margin — ALLO at -3566.68% versus CRMD at 40.49%.
How have ALLO and CRMD total returns compared?: Over the past 5 years, ALLO delivered -42.72% and CRMD delivered 9.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALLO analysis Full CRMD analysis Interactive comparison tool

Dig into the metrics

CorMedix P/E ratio Allogene Therapeutics ROE CorMedix ROE Allogene Therapeutics operating margin CorMedix operating margin Allogene Therapeutics revenue growth CorMedix revenue growth Allogene Therapeutics free cash flow CorMedix free cash flow

Allogene Therapeutics & CorMedix appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.